The U.S. Food and Drug Administration has launched its Enhanced Approach for Sampling and Testing (EAST) initiative to enhance monitoring of the quality of drugs available in the United States.
EAST combines modern testing technologies with traditional methods to help the FDA test more drugs across multiple manufacturers, therapeutic classes, and geographic regions. The initiative will help the agency identify potential quality issues faster.
